Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS

Dwight A Winter1, Katarzyna Karolewska-Bochenek, Izabella Lazowska-Przeorek

  • 11Pediatric Gastroenterology, Department of Pediatrics, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; 2Department of Pediatric Gastroenterology and Nutrition, The Medical University of Warsaw, Warsaw, Poland; 3Gastroenterology and Nutrition Unit, Meyer Pediatric Hospital, Florence, Italy; 4Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands; 5Department of Pediatric Gastroenterology, Queen Mary's Hospital for Children, Surrey, United Kingdom; 6First Department of Pediatrics, Athens University, Athens, Greece; 7Department of Pediatrics, Charles University in Prague, Hradec Kralove, Czech Republic; 8Department of Pediatric Gastroenterology, Helsinki Children's Hospital, Helsinki, Finland; 9Pediatric Gastroenterology Unit, Meyer Children's Hospital, Haifa, Israel; 10Department of Pediatrics, University of Naples, Naples, Italy; 11Department of Pediatric Gastroenterology, Radboud University Medical Centre, Nijmegen, the Netherlands; 12Department of Pediatric Gastroenterology, VU University Medical Center, Amsterdam, the Netherlands; 13Department of Pediatrics, Juliana Children's Hospital, The Hague, the Netherlands; 14Department of Pediatrics, Medical Center Alkmaar, Alkmaar, the Netherlands; and 15Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.

Insights

In pediatric Inflammatory Bowel Disease-Unclassified (IBD-U), only half of patients received complete diagnostic workup. Follow-up investigations reduced the IBD-U rate, highlighting the need for clear diagnostic criteria.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Research
  • Diagnostic Accuracy

Background:

  • Inflammatory Bowel Disease-Unclassified (IBD-U) is diagnosed in approximately 10% of pediatric and adolescent onset IBD cases.
  • The EUROKIDS registry prospectively monitors diagnostic workup for newly diagnosed pediatric IBD patients.

Purpose of the Study:

  • To describe the diagnostic workup, clinical phenotype, and diagnostic changes over time in pediatric IBD-U patients.
  • To evaluate the impact of diagnostic workup completeness on IBD-U diagnosis.

Main Methods:

  • Data collected from 52 centers across 20 European countries and Israel (May 2005-November 2013).
  • Complete diagnostic workup defined as full endoscopy plus small bowel radiology.
  • Follow-up data queried in 2014 for patients initially diagnosed with IBD-U.

Main Results:

  • IBD-U was the initial diagnosis in 7.7% of 3461 children; 48% had complete diagnostic workup.
  • Lack of small bowel radiology was the primary reason for incomplete workup.
  • After a median follow-up of 5.7 years, diagnosis changed from IBD-U to Crohn's disease (12%) or ulcerative colitis (20%) in 32% of cases.

Conclusions:

  • Incomplete diagnostic workup was common in pediatric IBD-U patients within the EUROKIDS registry.
  • Reinvestigations reduced the IBD-U rate to 5.6%, indicating diagnostic evolution.
  • Complete diagnostic workup decreases the likelihood of an IBD-U diagnosis; clear criteria are needed.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484